HTG Molecular Diagnostics Email Format

Biotechnology ResearchArizona, United States11-50 Employees

HTG Molecular Diagnostics is a Tucson, Arizona-based biotechnology research company focused on advancing precision medicine from diagnosis to treatment through transcriptome-wide profiling. Its work supports translational research, clinical diagnostics, and the development of targeted therapeutics across a range of disease areas. The company emphasizes proprietary RNA-based platform technologies designed to increase the efficiency and effectiveness of creating life-science tools and diagnostics, aiming to offer a differentiated approach to drug discovery.

Over more than a decade, HTG has built partnerships with biopharma leaders and major academic institutions, positioning itself as a collaborator in translational medicine. In late 2022 the company announced a collaboration with OmiCure to use its Transcriptome Panel for data generation in cancer therapeutic decision support.

Sign up for free to view info

Company overview Employee directory